论文部分内容阅读
本文报告201例胸膜结核患者,其中143例应用短程化疗(SCC),58例应用常规疗法(简称 CT)。发现SCC 治疗胸膜结核的疗效和 SCC 治疗肺结核一样,SCC 与 CT 相比,疗效相等或优于 CT。短程化疗(SCC)方案组成:每日口服异烟肼(INH)300mg 和利福平(RFP)600mg,治疗1个月,相继每周两次 INH(900mg/次)和 RFP(600mg/次)治疗8个月,前后共9个月。而常规疗法(CT)服药时间长达18～24个月。SCC 组平均年龄61.6岁(18～88岁),包括15岁以下5例。CT 组平均年龄59.3岁(18～94岁)。SCC 组
This article reports 201 cases of pleural tuberculosis, of which 143 cases were treated with short-term chemotherapy (SCC), 58 cases of conventional therapy (referred to as CT). Therapeutic efficacy of SCC in the treatment of pleural tuberculosis was the same as or superior to CT in SCC treatment of tuberculosis. Short-course chemotherapy (SCC) regimen: INH 300 mg and rifampicin 600 mg daily for 1 month, followed by INH (900 mg twice weekly) and RFP (600 mg once) Treatment for 8 months, before and after a total of 9 months. The conventional therapy (CT) medication for up to 18 to 24 months. The mean age of SCC patients was 61.6 years (18 to 88 years), including 5 under 15 years of age. The average age of CT group was 59.3 years (18-94 years). SCC group